tiprankstipranks
Immunome (IMNM)
NASDAQ:IMNM
US Market
Holding IMNM?
Track your performance easily

Immunome (IMNM) Technical Analysis

194 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Immunome’s (IMNM) Moving Averages Convergence Divergence (MACD) indicator is -0.79, suggesting Immunome is a Buy.
Immunome’s (IMNM) 20-Day exponential moving average is 11.42, while Immunome’s (IMNM) share price is $9.42, making it a Sell.
Immunome’s (IMNM) 50-Day exponential moving average is 12.42, while Immunome’s (IMNM) share price is $9.42, making it a Sell.

Immunome (IMNM) Pivot Points

Nov 21, 2024, 11:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.86
9.02
9.21
9.37
9.55
9.71
9.90
Fibonacci
9.02
9.16
9.24
9.37
9.50
9.58
9.71
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunome (IMNM) Moving Averages

Nov 21, 2024, 11:10 PM
Period
Simple
Exponential
MA5
9.84Sell
9.94Sell
MA10
11.21Sell
10.70Sell
MA20
11.75Sell
11.42Sell
MA50
12.81Sell
12.42Sell
MA100
13.44Sell
13.24Sell
MA200
16.05Sell
14.50Sell
Immunome’s (IMNM) 10-Day exponential moving average is 10.70, while Immunome’s (IMNM) share price is $9.42, making it a Sell.
Immunome’s (IMNM) 100-Day exponential moving average is 13.24, while Immunome’s (IMNM) share price is $9.42, making it a Sell.
Immunome’s (IMNM) stock price is $9.42 and Immunome’s (IMNM) 50-day simple moving average is 12.81, creating a Sell signal.
Immunome’s (IMNM) stock price is $9.42 and Immunome’s (IMNM) 100-day simple moving average is 13.44, creating a Sell signal.
Immunome’s (IMNM) stock price is $9.42 and Immunome’s (IMNM) 200-day simple moving average is 16.05, creating a Sell signal.

Immunome (IMNM) Technical Indicators

Nov 21, 2024, 11:10 PM
Name
Value
Implied Action
RSI (14)
28.05
Buy
STOCH (9,6)
4.41
Buy
STOCHRSI (14)
4.32
Buy
MACD (12,26)
-0.79
Buy
ADX (14)
23.46
Neutral
Williams %R
-92.32
Buy
CCI (14)
-178.94
Buy
ATR (14)
0.79
-
Ultimate Oscillator
30.21
Neutral
ROC
-18.66
Sell
Immunome’s (IMNM) Relative Strength Index (RSI) is 28.05, creating a Buy signal.
Immunome’s (IMNM) Trend Strength Indicator (ADX) is 23.46, creating a Neutral signal.
Immunome’s (IMNM) Commodity Channel Index (CCI) is -178.94, creating a Buy signal.
Immunome’s (IMNM) Price Rate of Change (ROC) is -18.66, creating a Sell signal.

FAQ

Is IMNM a Buy, Hold, or Sell?
Based on IMNM’s technical indicators, IMNM is a Sell.
    What is IMNM’s RSI (14)?
    IMNM’s RSI (14) is 28.05, which suggests IMNM is a Buy.
      What is IMNM’s MACD?
      IMNM’s MACD is -0.79, which suggests IMNM is a Buy.
        What is IMNM’s 5-day moving average?
        IMNM’s 5-day moving average is 9.84, which suggests IMNM is a Sell.
          What is IMNM’s 20-day moving average?
          IMNM 20-day moving average is 11.75, which suggests IMNM is a Sell.
            What is IMNM’s 50-day moving average?
            IMNM’s 50-day moving average is 12.81, which suggests IMNM is a Sell.
              What is IMNM’s 200-day moving average?
              IMNM’s 200-day moving average is 16.05, which suggests IMNM is a Sell.
                What is IMNM’s Williams % R (14)?
                IMNM’s Williams % R (14) is -92.32, which suggests IMNM is a Buy.
                  What is IMNM’s CCI (14)?
                  IMNM’s CCI (14) is -178.94, which suggests IMNM is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis